In this final installment of the "Breaking down diabetes" series, physician-researcher Randall Stafford weighs in on a debate about blood sugar levels that relates to drug prices.
Category: Organization
Expanding hepatitis C testing to all adults is cost-effective and improves health, new study shows
Even adults who are not considered "high-risk" should be tested to reduce deaths and improve cure rates, new Stanford Health Policy research suggests.
A look at cervical cancer prevention and screening
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Exercise elevates blood signature difference between people with, without chronic fatigue syndrome
A new study suggests that a blood test following exercise may be a good way to differentiate between people who have ME/CFS and people who don't.
Too high: Current blood pressure targets may not be low enough
In this fifth, final post in a series on high blood pressure, Randall Stafford, MD, PhD, explains target blood pressure guidelines.
Too high: Side effects hamper many blood pressure medications
In this piece in a series on high blood pressure, Randall Stafford, MD, PhD, tackles the problems caused by the side effects of medications.
Donor gift leads to innovative cancer clinical trial
When Jeff Schottenstein's wife was diagnosed with gastric cancer in 2014, he immediately jumped into action and left no stone un-turned in researching potential solutions to …